company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,82405000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5459000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1145000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89009000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3516000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,200000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3716000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,,totalassets,Total Assets,=,debit,usd,97634000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6043000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6362000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,264000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1541000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1805000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8167000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,458988000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-366496000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-284000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,89467000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,89467000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,89467000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,,2011-06-30,2011-08-09 16:47:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,97634000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56099000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2403000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,960000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,59462000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4004000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3240000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,200000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3440000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,,totalassets,Total Assets,=,debit,usd,66906000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4099000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4418000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,111000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,963000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5492000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,466175000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-401760000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-260000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,61414000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,61414000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,61414000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,,2012-03-31,2012-05-08 17:18:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66906000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47820000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2096000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1061000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,50977000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3915000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3240000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,200000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3440000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,,totalassets,Total Assets,=,debit,usd,58332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3983000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4302000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,60000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,999000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1059000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5361000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,468452000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-412480000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-260000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,52971000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,52971000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,52971000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,,2012-06-30,2012-08-09 13:03:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,58332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41096000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1129000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1186000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,43411000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3650000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3240000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,200000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3440000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,,totalassets,Total Assets,=,debit,usd,50501000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6805000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1039000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1048000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7853000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,469430000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-423781000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-260000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,42648000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,42648000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,42648000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,,2012-09-30,2012-11-08 15:15:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,50501000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55284000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1591000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1774000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,58649000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3384000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3148000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,40002000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,150000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,43300000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,,totalassets,Total Assets,=,debit,usd,105333000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7837000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,426000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8378000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12683000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16982000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29665000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,38043000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,505646000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-435363000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-252000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,67290000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,67290000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,67290000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,,2013-03-31,2013-05-10 15:42:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,105333000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,79221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1250000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1453000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81924000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2676000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2208000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,40002000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,150000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,42360000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,,totalassets,Total Assets,=,debit,usd,126960000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5961000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,106000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6182000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12683000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16815000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29498000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,35680000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,541839000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-447626000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-192000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,91280000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,91280000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,91280000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,,2013-06-30,2013-08-09 12:17:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,126960000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75597000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,754000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77572000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2526000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2208000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,40002000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,150000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,42360000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,,totalassets,Total Assets,=,debit,usd,122458000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5904000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,53000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6072000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12683000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16815000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29498000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,35570000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,547947000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-458126000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-192000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,86888000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,86888000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,86888000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,,2013-09-30,2013-11-12 09:54:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,122458000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,94036000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,817000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2845000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,97698000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2280000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2208000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39080000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,158000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41446000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,,totalassets,Total Assets,=,debit,usd,141424000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3981000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4096000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12321000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17113000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29434000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33530000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,586817000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-475990000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-192000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,107894000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,107894000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,107894000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,,2014-03-31,2014-05-09 10:40:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,141424000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,85347000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1468000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1943000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,88758000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2203000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2208000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39079000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41444000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,,totalassets,Total Assets,=,debit,usd,132405000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4237000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4352000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12320000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17512000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29832000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,34184000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,588217000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-487063000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-192000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,98221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,98221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,98221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,,2014-06-30,2014-08-08 14:01:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,132405000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,85230000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2208000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,41667000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1994000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,131099000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2321000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38502000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,38659000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,,totalassets,Total Assets,=,debit,usd,172079000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6039000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6154000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12093000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18012000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30105000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,36259000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,588841000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-450088000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-192000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,135820000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,135820000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,135820000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,,2014-09-30,2014-11-07 15:47:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,172079000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,108430000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,152000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3006000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,111588000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2473000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,36402000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36559000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,,totalassets,Total Assets,=,debit,usd,150620000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5301000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5416000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18399000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29731000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,35147000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,590735000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-472521000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,115473000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,115473000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,115473000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,,2015-03-31,2015-05-06 14:32:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,150620000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,99309000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1409000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2633000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,103351000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2524000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,36402000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36559000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,,totalassets,Total Assets,=,debit,usd,142434000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6516000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6631000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19186000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30518000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,37149000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,592244000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-484218000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,105285000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,105285000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,105285000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,,2015-06-30,2015-08-06 17:09:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142434000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90438000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1519000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5967000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,97924000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2428000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,36402000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,158000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36560000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,,totalassets,Total Assets,=,debit,usd,136912000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9827000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,115000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9942000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18974000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30306000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,40248000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,593637000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-494232000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,96664000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,96664000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,96664000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,,2015-09-30,2015-11-09 17:12:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,136912000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65675000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2434000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5122000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,73231000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2299000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30740000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1693000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45507000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,,totalassets,Total Assets,=,debit,usd,121037000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1500000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9742000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,126000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11368000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11199000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19975000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31174000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42542000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,595178000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-514034000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-92000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78311000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78311000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,184000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78495000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,,2016-03-31,2016-05-05 16:32:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,121037000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60146000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3563000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5338000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,69047000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3702000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30687000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1694000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45455000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,,totalassets,Total Assets,=,debit,usd,118204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1065000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12052000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,312000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13429000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11199000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19738000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30937000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,44366000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,596149000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-519672000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-64000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73672000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73672000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,166000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73838000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,,2016-06-30,2016-08-04 16:09:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,118204000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98894000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3942000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3776000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,106612000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3899000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30634000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2718000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46426000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,,totalassets,Total Assets,=,debit,usd,156937000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12696000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,26000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13822000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,11199000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,20885000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,32084000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,45906000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,597070000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-483369000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-74000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,110886000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,110886000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,145000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,111031000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,,2016-09-30,2016-11-07 16:37:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,156937000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,126306000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2097000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3676000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,132079000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4702000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30528000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2471000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46073000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,,totalassets,Total Assets,=,debit,usd,182854000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,971000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12705000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,677000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14353000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,48850000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,13010000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17386000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,79246000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,93599000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,598996000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-506933000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-67000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,89255000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,89255000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,89255000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,,2017-03-31,2017-05-04 16:51:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,182854000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,113959000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2715000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3269000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119943000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4563000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30475000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2472000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46021000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,,totalassets,Total Assets,=,debit,usd,170527000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1241000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1132000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14106000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16479000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,48322000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,13010000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18166000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,79498000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,95977000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,600914000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-523569000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-54000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,74550000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,74550000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,74550000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,,2017-06-30,2017-08-09 09:10:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,170527000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98279000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2619000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1662000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,102560000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4352000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30422000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2474000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45970000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,,totalassets,Total Assets,=,debit,usd,152882000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1839000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1116000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10104000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13059000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,47786000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,13010000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18947000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,79743000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,92802000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,601776000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-538921000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-34000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,60080000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,60080000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,60080000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,,2017-09-30,2017-11-02 16:27:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,152882000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,83431000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2444000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3512000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2455000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,91842000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3905000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30316000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1524000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44914000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,,totalassets,Total Assets,=,debit,usd,140661000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4735000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1596000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7920000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14251000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,45015000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1575000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19201000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,65791000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,80042000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,619136000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-554975000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-51000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-750000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,60619000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,60619000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,60619000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,,2018-03-31,2018-05-09 16:02:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,140661000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87490000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2176000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,93509000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4139000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30263000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1526000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44863000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,,totalassets,Total Assets,=,debit,usd,142511000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4766000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,548000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9437000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14751000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,42878000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1480000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,20573000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,64931000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,79682000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,635806000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-570147000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-89000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,62829000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,62829000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,62829000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,,2018-06-30,2018-07-31 17:15:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142511000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,148851000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5821000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2237000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,156909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3977000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13074000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6893000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1529000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21496000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,,totalassets,Total Assets,=,debit,usd,182382000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8216000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,629000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7650000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16495000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,38332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,26000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12646000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51004000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,712221000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-594504000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-93000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,114883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,114883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,114883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,,2018-09-30,2018-11-08 16:01:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,182382000.0
